Diligence memo · auto-generated · as of July 2, 2026

Akadeum Life Sciences, Inc.

Akadeum Life Sciences, Inc. looks fair against its niche peers and is active on financing cadence.

Diligence furtherNo decisive signal either way from the public record alone — the call needs primary diligence beyond the filings.

Businessfiled

Akadeum Life Sciences, Inc. operates in Other Health Care, based in ANN ARBOR.

No verified homepage on file yet — operating evidence is limited to the public record.

Capital & rounds (filed)filed

Akadeum Life Sciences, Inc. has raised $15M in disclosed capital across 7 recorded rounds, aggregated from public filings. Its latest round is modeled as Series A (a $4.0M–$15M round).

Largest single filing: $6.0M on 2023-05-16.

Most recent recorded round closed around 2025-04-11.

Valuation (modeled)modeled

Provath models Akadeum Life Sciences, Inc. at approximately $21M (range $7.2M–$37M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.

Read: Fair. Modeled value is 1.26× the median modeled value of Series A Other Health Care companies in 2025–2027 (83 peers) — value vs value, same stage and era. Within the normal band (126% of peer median) for its niche.

Financing rhythm & timingmixed

Historic cadence: a new round about every 11 months.

Last raise 15 mo ago; this sector typically re-raises about every 14 months.

Raising on or ahead of the sector's normal rhythm.

The last round was 1.1× smaller than the prior — a bridge or down round.

Comparablesmixed

Capital scale ranks ahead of 81% of Other Health Care peers (5377 compared).

Modeled value ranks above 49% of those peers.

Closest niche peers: HelloJoy, Inc., Maui Imaging, Inc., Celltrio, Inc., Medmo, Inc., Vertical Orthopaedics, Inc..

Peoplefiled

13 named people on file across officers, directors and signatories.

Risks & flagsmixed

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.